GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Other Current Receivables

Citi Pharma (KAR:CPHL) Other Current Receivables : ₨0.00 Mil (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Other Current Receivables?

Citi Pharma's Other Current Receivables for the quarter that ended in . 20 was ₨0.00 Mil.


Citi Pharma Other Current Receivables Historical Data

The historical data trend for Citi Pharma's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Other Current Receivables Chart

Citi Pharma Annual Data
Trend
Other Current Receivables

Citi Pharma Semi-Annual Data
Other Current Receivables

Citi Pharma Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Citi Pharma Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Citi Pharma Business Description

Traded in Other Exchanges
N/A
Address
588 Q Block, Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines